Market Definition
Smart implants are implantable medical devices embedded with sensors that provide real-time information about the body's inside environment. With both therapeutic & diagnostic benefits, these devices aid healthcare professionals in tailoring treatments and detecting adverse events beforehand. Incorporating smart implants into daily clinical practice can provide remarkable benefits to the entire healthcare system, such as shorter recovery time, less number of lost workdays post-operation, and fewer readmissions & complications.
Market Insights
The Germany Smart Implants Market is expected to grow at around 9% CAGR during the forecast period, i.e., 2023-28. With growing adaption to changing technologies & market trends, Germany is one of the fastest-growing smart implants markets. For years, the country has proved as the center for conducting remarkable R&D and clinical trials and possesses cutting-edge medical technologies.
Report Coverage | Details |
---|---|
Study Period | Historical Data: 2018-21 |
Base Year: 2022 | |
Forecast Period: 2023-28 | |
CAGR (2023-2028) | 9% |
Key Companies Profiled | Abbott, AstraZeneca, Boston Scientific Medizintechnik GmbH, Cochlear Ltd., Biotronik, Integra LifeSciences, Johnson & Johnson Services Inc., Medtronic GmbH, Nevro Corp., Neuropace, Inc., Others |
Unit Denominations | USD Million/Billion |
The growth of the market would be driven primarily by rapid developments in the healthcare sector, the mounting focus of medical professionals on providing pervasive & personalized care to patients, and the inclusion of minimally-invasive methods in implants. Besides, the growing prevalence of orthopedic disorders like osteoarthritis, Carpal Tunnel Syndrome, tumors, etc., are also projected to propel the smart implants market growth in the country.
Smart implants help healthcare professionals collect real-time health data, monitor chronic ailments, and provide patient-tailored treatment. These devices have a strong potential to minimize underlying medical complications, reduce recovery time, and minimize readmissions & revision procedures. Rigorous research & continuous developments in various therapeutic approaches, alongside significant advancements in power transfer, sensing, energy storage, & smart communication techniques, are also creating new prospects for companies operating in the Germany Smart Implants Market.
In addition, the growing utilization of computer-guided implant surgeries to improve predictability & ensure secure stabilization, coupled with innovations in wireless communication technology, control monitoring, & smooth assessment of implants using the latest technologies, would further stimulate the growth of the smart implants industry in Germany over the forecast years.
Market Segmentation
Based on Product Type:
Of them all, orthopedic implants are projected to acquire the majority share of the Germany Smart Implants Market during 2023-28. It owes to the increasing number of orthopedic surgeries like TKA (Total Knee Arthroplasty), total hip arthroplasty, & UKA (Unicompartmental Knee Arthroplasty), mainly due to the growing incidence of knee & hip disorders in the country, i.e., leading to the increasing number of replacement procedures for the same and, consequently, burgeoning demand for orthopedic implants.
Smart hip implants have the ability to detect pressure & temperature measurements, as well as the loosening of prostheses, i.e., one of the most common complications of total hip arthroplasty. Primary TKA is among the most performed surgical procedures in the country for patients, typically the elderly, with knee deformity, chronic knee inflammation, or osteoarthritis that leads to severely damaged knee joints.
In recent years, the German healthcare sector has observed significant advances in surgical methods, comprehensive blood management, multimodal pain management, & post-operative care management. Hence, these trends are set to create new avenues for the smart implants market to witness notable expansion in the nearer future.
Based on Material:
Here, titanium holds a significant share of the smart implants market. Titanium & its alloys have excellent corrosion resistance & hard-tissue compatibility that aids in bone formation & bonding, owing to which they are used widely as artificial joints, bone fixators, spinal fixators, dental implants, etc.
The non-allergic nature, superior strength, lower costs than other materials, higher success rate, suitability for almost all procedures, and excellent biocompatibility are the prime aspects contributing to the mounting demand for titanium implants and, in turn, fueling the growth of the Germany Smart Implants Market.
However, polyethylene is likely to acquire a notable market share in the coming years, mainly due to the increasing number of hip replacement surgeries in Germany. It is porous, biologically inert, and doesn't degrade in the body; therefore considered an ideal implant material to substantially minimize the need for revision surgery after a total hip replacement.
Based on End-User:
Of them all, hospitals would continue their dominance in the Germany Smart Implants Market with the largest share during 2023-28. Smart pacemakers, defibrillators, cochlear, ocular, & most orthopedic surgeries involving implants are performed majorly in hospitals owing to the high level of complexities associated with these procedures.
Technological advancements in healthcare and various ongoing R&D on smart implants between various medical institutions & hospitals in the country have made hospitals the preferred choice of patients seeking treatments. With the growing number of elective surgeries in public & private hospitals, smart implants are witnessing a continuously evolving demand across Germany. Hence, these aspects indicate that the smart implants industry would generate the highest revenue from hospitals over the forecast years.
Key Questions Answered in the Market Research Report:
Frequently Asked Questions
A. The Germany Smart Implants Market is projected to register around 9% CAGR during 2023-28.
A. The mounting incidence of orthopedic disorders, remarkable innovations & developments in the healthcare sector, and increasing focus on providing pervasive & personalized patient care services are the prime aspects expected to drive the Germany Smart Implants Market during 2023-28.
A. Abbott, AstraZeneca, Boston Scientific Medizintechnik GmbH, Cochlear Ltd., Biotronik, Integra LifeSciences, Johnson & Johnson Services, Inc., Medtronic GmbH, Nevro Corp., and Neuropace, Inc. are the key companies participating in the Germany Smart Implants Market.
A. Titanium would emerge as an area of remunerative opportunities for the leading players in the Germany Smart Implants Market during 2023-28.